Diovan®
Valsartan is an ARB used for hypertension, heart failure, and post-MI left ventricular dysfunction. Also available in combination with sacubitril.
| Dosage Form | Oral Tablet / Capsule |
| Strength | 40 mg, 80 mg, 160 mg, 320 mg |
| Storage | Store at 25°C. Protect from moisture. |
| Category | Cardiovascular |
| Availability | Available for Transfer |
Hypertension; heart failure (NYHA II-IV); post-MI LV dysfunction/failure.
Blocks AT1 receptor, inhibiting angiotensin II-mediated vasoconstriction, sympathetic activation, and aldosterone secretion.
Each Burrard Pharmaceuticals technology transfer package for Valsartan includes comprehensive documentation and support:
Complete formulation with manufacturing parameters, excipient specifications, and process controls.
Validated methods for assay, impurities, dissolution, and stability-indicating analysis.
Market-ready regulatory dossier templates — available through Burrard Intelligence subscription.
ICH-compliant stability studies (accelerated and long-term) with detailed protocols.
Scale-up procedures, batch records, equipment specifications, and in-process controls.
Direct advisory access to formulation scientists and regulatory specialists throughout transfer.
Our team can deliver the complete know-how package within 2–21 business days. Book a consultation to discuss your specific requirements.